Skip to Main Content

Paper Details

Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease: A Head-to-Head Comparison Against Amyloid Positron Emission Tomography and Magnetic Resonance Imaging.
JAMA Neurol
129
2021
18F, A, AD, AD dementia, APOE, APOE genotype, Alzheimer Disease, Alzheimer disease, MCI, Participants, Tau, [18F], [18F]Flortaucipir, [18F]RO948, [18F]flortaucipir, amyloid- [A], cognitively unimpaired, dementia, flortaucipir, fluorine 18, mild cognitive impairment, participants, tau
Author NameAffiliation
Tomas OlssonSkane University Hospital
Adam L BoxerUniversity of California san francisco
Bruce L MillerUniversity of California san francisco
Michael D Devous
William J JagustLawrence Berkeley National Laboratory
William J JagustHelen Wills Neuroscience Institute, University of California berkeley
  • 1 - 6

Datasets

Release 1.2